Pharmaceutical Industry Information Portal

HomeTagsAtara Biotherapeutics

All posts by tag

Atara Biotherapeutics

Bayer intends to discontinue partnership with Atara on CAR-T for $670 million

Atara Biotherapeutics, Inc., a leader in T-cell immunotherapy, leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with cancer and...
spot_img

Expert Articles

spot_img